The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations

Autor: Paul S. Tofts, Anwar R. Padhani, D McIntyre, R. J. Maxwell, Patricia M Price, Gordon C Jayson, Gordon J. S. Rustin, John C. Waterton, Ian Judson, Paul Workman, Martin O. Leach, John R. Griffiths, Michael R. Horsman, R Rathbone, Kevin M. Brindle, Alan Jackson, Jeffrey L. Evelhoch, Stephen R. Williams, W Vennart, Michael V. Knopp, Gillian M. Tozer
Jazyk: angličtina
Rok vydání: 2005
Předmět:
antivascular
Cancer Research
Bone marrow transplant
medicine.medical_specialty
BRAIN-TUMORS
Cancer therapy
Angiogenesis Inhibitors
Antineoplastic Agents
GADOPENTETATE DIMEGLUMINE
ANGIOGENESIS
BREAST-TUMORS
magnetic resonance
CONTRAST-ENHANCED MRI
Neoplasms
Terminology as Topic
END-POINTS
Clinical Studies
medicine
therapeutic trials
1112 Oncology and Carcinogenesis
Medical physics
Oncology & Carcinogenesis
Stage (cooking)
Clinical Trials as Topic
Science & Technology
medicine.diagnostic_test
business.industry
Reproducibility of Results
Magnetic resonance imaging
antiangiogenic
QUANTITATIVE-ANALYSIS
equipment and supplies
CANCER
Therapeutic trial
Magnetic Resonance Imaging
Biomarker (cell)
Surgery
Clinical trial
CEREBRAL BLOOD-VOLUME
Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee
Drug Development Office
Cancer Research UK

Oncology
Evaluation Studies as Topic
ENDOTHELIAL GROWTH-FACTOR
Anti cancer drugs
biomarker
cancer therapy
business
Life Sciences & Biomedicine
human activities
Zdroj: British Journal of Cancer
Leach, M O, Brindle, K M, Evelhoch, J L, Griffiths, J R, Horsman, M R, Jackson, A, Jayson, C G, Judson, I R, Knopp, M V, Maxwell, R J, McIntyre, D, Padhani, A R, Price, P, Rathbone, R, Rustin, G J, Tofts, P S, Tozer, G M, Vennart, W, Waterton, J C, Williams, S R & Workman, P 2005, ' The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations ', Br. J. Cancer, vol. 92, no. 9, pp. 1599-1610 . https://doi.org/10.1038/sj.bjc.6602550
94th Annual Meeting of the American-Association-for-Cancer-Research
ISSN: 1532-1827
0007-0920
Popis: Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.\ud \ud \ud
Databáze: OpenAIRE